SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/293187"
 

Search: onr:"swepub:oai:gup.ub.gu.se/293187" > Identification of n...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning

Hedman, A. K. (author)
Karolinska Institutet
Hage, C. (author)
Karolinska Institutet
Sharma, A. (author)
show more...
Brosnan, M. J. (author)
Buckbinder, L. (author)
Gan, Li-Ming, 1969 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
Shah, S. J. (author)
Linde, C. M. (author)
Donal, E. (author)
Daubert, J. C. (author)
Malarstig, A. (author)
Karolinska Institutet
Ziemek, D. (author)
Lund, L. (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2020-01-07
2020
English.
In: Heart. - : BMJ. - 1355-6037 .- 1468-201X. ; 106:5, s. 342-349
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome. We aimed to derive HFpEF phenotype-based groups ('phenogroups') based on clinical and echocardiogram data using machine learning, and to compare clinical characteristics, proteomics and outcomes across the phenogroups. Methods We applied model-based clustering to 32 echocardiogram and 11 clinical and laboratory variables collected in stable condition from 320 HFpEF outpatients in the Karolinska-Rennes cohort study (56% female, median 78 years (IQR: 71-83)). Baseline proteomics and the composite end point of all-cause mortality or heart failure (HF) hospitalisation were used in secondary analyses. Results We identified six phenogroups, for which significant differences in the prevalence of concomitant atrial fibrillation (AF), anaemia and kidney disease were observed (p<0.05). Fifteen out of 86 plasma proteins differed between phenogroups (false discovery rate, FDR<0.05), including biomarkers of HF, AF and kidney function. The composite end point was significantly different between phenogroups (log-rank p<0.001), at short-term (100 days), mid-term (18 months) and longer-term follow-up (1000 days). Phenogroup 2 was older, with poorer diastolic and right ventricular function and higher burden of risk factors as AF (85%), hypertension (83%) and chronic obstructive pulmonary disease (30%). In this group a third experienced the primary outcome to 100 days, and two-thirds to 18 months (HR (95%CI) versus phenogroups 1, 3, 4, 5, 6: 1.5 (0.8-2.9); 5.7 (2.6-12.8); 2.9 (1.5-5.6); 2.7 (1.6-4.6); 2.1 (1.2-3.9)). Conclusions Using machine learning we identified distinct HFpEF phenogroups with differential characteristics and outcomes, as well as differential levels of inflammatory and cardiovascular proteins.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

predicting survival
risk score
association
dysfunction
subgroups
therapies
outcomes
Cardiovascular System & Cardiology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Heart (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view